Head-to-head for women
Direct Meds vs RxSpan MD
Direct Meds and RxSpan MD both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
Direct Meds
Ranked #30 for women · Grade B−
Luna Fit
Best for: Women who want an oral or sublingual alternative to weekly shots, on an all-inclusive program with no membership fee, and who are comfortable vetting a newer compounder themselves.
Visit Direct MedsRxSpan MD
Higher scoreRanked #11 for women · Grade B
Luna Fit
Best for: Women who prioritize an accredited, brand-capable program with an oral route and don't mind paying at the higher end.
Visit RxSpan MDThe verdict for women
RxSpan MD edges out Direct Meds on the Luna Fit Score, 86 to 82 (B vs B−). Women who prioritize an accredited, brand-capable program with an oral route and don't mind paying at the higher end.
Direct Meds is still a genuine option — one of the few programs we track that offers an oral or sublingual route alongside injections — semaglutide drops from about $179 (or $297 injectable), tirzepatide from about $224 — all-inclusive with no separate membership. The trade-off is a newer, less-verified operator whose prices we couldn't confirm live. Weigh the six women's-health factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Direct Meds | RxSpan MD |
|---|---|---|
| Luna Fit Score | 82/100 · B− | 86/100 · B |
| Overall rank | #30 | #11 |
| Semaglutide | $179/mo | $249/mo |
| Tirzepatide | $224/mo | $329/mo |
| Coverage | Not publicly listed | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Yes | Yes |
Luna Fit
Direct Meds
Ranked #30 · Grade B−
What we like
- Rare oral and sublingual route in addition to injectable — a real option for the needle-averse
- Both molecules offered — semaglutide and tirzepatide for insulin-resistant PCOS
- All-inclusive pricing with no separate membership fee, and a promotional entry near $147
The caveats
- Compounded only — no FDA-approved brand semaglutide or tirzepatide
- Prices are company-stated, not ones we could verify live, and the brand runs multiple domains
- A newer operator with an ambiguous footprint, so the oversight signal is thinner
Luna Fit
RxSpan MD
Ranked #11 · Grade B
What we like
- FDA-approved brand access, oral option, and both molecules on one account
- LegitScript-accredited, nationwide across all 50 states
- Comprehensive feature set for women who want every option available
The caveats
- Highest-tier pricing among the accredited options — $249 semaglutide, $329 tirzepatide
- General metabolic program, not hormone-specialized
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Luna Fit Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing Direct Meds and RxSpan MD against other providers we review for women.
- Direct Meds vs CoreAge Rx
- Direct Meds vs Eden
- Direct Meds vs Ondra Health
- RxSpan MD vs Found
- RxSpan MD vs Vytora Health
- RxSpan MD vs Effecty
Or browse the full comparison hub.